Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-21 Sale | 2024-03-25 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 14,491 | $35.31 | $511,677 | 21,315 (Direct) | View |
| 2024-03-20 Sale | 2024-03-22 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 400 | $35.31 | $14,124 | 35,806 (Direct) | View |
| 2024-03-19 Sale | 2024-03-21 5:01 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 12,364 | $35.31 | $436,573 | 36,206 (Direct) | View |
| 2024-03-13 Sale | 2024-03-15 6:39 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 62,366 | $33.74 | $2,104,289 | 17,320 (Direct) | View |
| 2024-03-12 Sale | 2024-03-14 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,884 | $32.99 | $128,133 | 44,686 (Direct) | View |
| 2024-02-26 Sale | 2024-02-28 5:01 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 5,000 | $30.21 | $151,050 | 8,570 (Direct) | View |
| 2024-01-10 Sale | 2024-01-12 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,000 | $27.91 | $223,280 | 85,664 (Direct) | View |
| 2023-11-16 Sale | 2023-11-20 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 2,500 | $28.01 | $70,025 | 117,089 (Direct) | View |
| 2023-11-15 Sale | 2023-11-17 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 9,093 | $28.5 | $259,151 | 33,231 (Direct) | View |
| 2023-11-14 Sale | 2023-11-16 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,110 | $28.13 | $31,224 | 5,681 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-21 Exercise | 2024-03-25 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 14,491 | $25.3 | 21,315 (Direct) | View |
| 2024-03-21 Exercise | 2024-03-25 5:00 pm | N/A 2027-02-24 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 14,491 | $0 | 21,315 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 400 | $25.3 | 35,806 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 5:00 pm | N/A 2027-02-24 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 400 | $0 | 35,806 (Direct) | View |
| 2024-03-19 Exercise | 2024-03-21 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 12,364 | $25.3 | 36,206 (Direct) | View |
| 2024-03-19 Exercise | 2024-03-21 5:01 pm | N/A 2027-02-24 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 12,364 | $0 | 36,206 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 6:39 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 26,250 | $23.99 | 17,320 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 6:39 pm | N/A 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 62,366 | $0 | 17,320 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 6:39 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 36,116 | $12.98 | 17,320 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 5:00 pm | N/A 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,884 | $0 | 44,686 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-14 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,884 | $12.98 | 44,686 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 990 | $0 | 7,779 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 460 | $27.94 | 7,779 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 35,000 | $0 | 1,937,667 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 16,788 | $27.94 | 1,937,667 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-28 5:01 pm | N/A 2025-03-03 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 5,000 | $0 | 8,570 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-28 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 5,000 | $9.13 | 8,570 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,886 | $0 | 120,975 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 3,886 | $0 | 120,975 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 3,886 | $0 | 17,201 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 3,886 | $0 | 17,201 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 3,886 | $0 | 17,201 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 3,886 | $0 | 17,201 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:03 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 3,886 | $0 | 37,117 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:03 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 3,886 | $0 | 37,117 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director | 3,886 | $0 | 87,943 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director | 3,886 | $0 | 87,943 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 937 | $29.06 | 12,874 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,875 | $0 | 12,874 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,875 | $0 | 12,874 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 638 | $29.06 | 12,320 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,250 | $0 | 12,320 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,250 | $0 | 12,320 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 1,314 | $29.06 | 14,690 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 2,500 | $0 | 14,690 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 2,500 | $0 | 14,690 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 567 | $29.06 | 8,391 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,250 | $0 | 8,391 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,250 | $0 | 8,391 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 485 | $29.06 | 90,683 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 1,250 | $0 | 90,683 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 1,250 | $0 | 90,683 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:03 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 13,621 | $0 | 26,936 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:02 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 13,621 | $0 | 26,936 (Direct) | View |
| 2024-02-22 Tax Withholding | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 303 | $27.94 | 35,458 (Direct) | View |
| 2024-02-22 Disposition | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 750 | $0 | 35,458 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 30,750 | $0 | 35,458 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:02 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 13,621 | $0 | 130,710 (Direct) | View |
| 2024-02-22 Tax Withholding | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 372 | $27.94 | 34,458 (Direct) | View |
| 2024-02-22 Disposition | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 750 | $0 | 34,458 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 25,750 | $0 | 34,458 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:01 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | SIEBERT JOHN M Director | 13,621 | $0 | 97,678 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:01 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 13,621 | $0 | 13,621 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:01 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 13,621 | $0 | 46,852 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:01 pm | N/A 2034-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 357,000 | $0 | 2,276,455 (Direct) | View |
| 2024-02-22 Tax Withholding | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 335 | $27.94 | 38,801 (Direct) | View |
| 2024-02-22 Disposition | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 750 | $0 | 38,801 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 31,740 | $0 | 38,801 (Direct) | View |
| 2024-02-22 Disposition | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 500 | $0 | 69,004 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 62,500 | $0 | 69,004 (Direct) | View |
| 2024-02-22 Tax Withholding | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 246 | $27.94 | 87,668 (Direct) | View |
| 2024-02-22 Disposition | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 87,668 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 87,668 (Direct) | View |
| 2024-02-12 Other | 2024-02-22 5:28 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 16,500 | $0 | 1,952,455 (Direct) | View |
| 2024-01-10 Exercise | 2024-01-12 5:00 pm | N/A 2024-01-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,000 | $0 | 85,664 (Direct) | View |
| 2024-01-10 Exercise | 2024-01-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,000 | $9.24 | 85,664 (Direct) | View |
| 2023-12-22 Tax Withholding | 2023-12-26 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan Sr. VP, Chief Medical Officer | 204 | $27.66 | 3,243 (Direct) | View |
| 2023-12-22 Exercise | 2023-12-26 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan Sr. VP, Chief Medical Officer | 600 | $0 | 3,243 (Direct) | View |
| 2023-12-22 Tax Withholding | 2023-12-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 11,958 | $27.66 | 1,919,455 (Direct) | View |
| 2023-12-22 Exercise | 2023-12-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 25,000 | $0 | 1,919,455 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 25,000 | $0 | 1,931,413 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 600 | $0 | 3,447 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 5:00 pm | 2015-01-21 2024-01-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 7,457 | $0 | 117,089 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 7,457 | $9.24 | 117,089 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 5:00 pm | 2015-01-21 2024-01-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 7,457 | $0 | 33,231 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 7,457 | $9.24 | 33,231 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 5:00 pm | N/A 2024-01-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 2,000 | $0 | 5,681 (Direct) | View |
| 2023-11-14 Exercise | 2023-11-16 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 2,000 | $9.24 | 5,681 (Direct) | View |
| 2023-10-13 Exercise | 2023-10-13 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 4,000 | $0 | 5,089 (Direct) | View |
| 2023-10-13 Tax Withholding | 2023-10-13 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 1,911 | $26.91 | 5,089 (Direct) | View |